Full name
"POLSKA GRUPA FARMACEUTYCZNA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.18.Z - Agents specialised in the sale of other particular products
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
46.90.Z - Non-specialised wholesale trade
49.41.Z - Freight transport by road
68.20.Z - Rental and operating of own or leased real estate
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.E - Other human health activities notelsewhere classified
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,4 | 36,9 | |
Gross profit (loss) | 1,1 | 0,9 | 1 | 6,4 |
EBITDA | 1,4 | 1,2 | 1,3 | 2,2 |
Short time liabilities | 1,9 | 1,2 | 1,1 | -7,3 |
Other operating costs | 0 | 0 | -50,6 | |
Equity capital | 2,2 | 2,2 | 2,2 | 3,8 |
Operating profit (EBIT) | 1,1 | 0,9 | 1 | 4 |
Assets | 5 | 4,2 | 4,2 | -0,5 |
Net profit (loss) | 0,9 | 0,7 | 0,8 | 7,2 |
Cash | 0,1 | 0,1 | 0,1 | -5,5 |
Net income from sale | 10 | 10,2 | 9,2 | -9,6 |
Liabilities and provisions for liabilities | 2,8 | 2,1 | 2 | -5 |
Working assets | 2 | 1,3 | 1,6 | 15,3 |
Other income costs | 0,7 | 0,6 | -11,1 | |
Depreciation | 0,3 | 0,3 | 0,3 | -3,3 |
% | % | % | p.p. | |
Profitability of capital | 38,7 | 33,9 | 35,1 | 1,2 |
Equity capital to total assets | 43,6 | 50,8 | 53 | 2,2 |
Gross profit margin | 11 | 9,1 | 10,7 | 1,6 |
EBITDA Margin | 13,9 | 12,1 | 13,7 | 1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 70 | 43 | 44 | 1 |
Current financial liquidity indicator | 0.7364578247070312 | 1.1159769296646118 | 1.3888088464736938 | 0,3 |
Net dept to EBITDA | 0.38503018021583557 | -0.07388018816709518 | -0.06832396984100342 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane